Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Ocuphire Pharma
OCUP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.32
-0.14
-9.28%
Pre-Market: Sep 19, 7:32 AM EDT
15 minutes delayed
Get Report
Comment
Ocuphire Pharma (OCUP) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Ocuphire Pharma (NASDAQ:OCUP) Stock
Ocuphire Pharma Stock (NASDAQ: OCUP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 05, 2024
Ocuphire Pharma Initiates VEGA-3 Phase 3 Tria...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Maintains Buy on Ocuphire...
Benzinga Newsdesk
Wednesday, August 14, 2024
Canaccord Genuity Maintains Buy on Ocuphire P...
Benzinga Newsdesk
Tuesday, August 13, 2024
Ocuphire Pharma shares are trading lower afte...
Benzinga Newsdesk
Ocuphire Pharma Q2 EPS $(0.30) Misses $(0.24)...
Benzinga Newsdesk
Wednesday, July 10, 2024
Ocuphire Pharma Participates In ARVO SIG Pane...
Benzinga Newsdesk
Thursday, June 06, 2024
Ocuphire Pharma Announces Upcoming Presentati...
Benzinga Newsdesk
Wednesday, May 22, 2024
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor
Monday, May 13, 2024
Canaccord Genuity Maintains Buy on Ocuphire P...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Ocuphir...
Benzinga Newsdesk
Friday, May 10, 2024
Ocuphire Pharma Q1 2024 GAAP EPS $(0.29) Miss...
Benzinga Newsdesk
Thursday, April 11, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Ocuphire Pharma Announces First Patient Enrol...
Benzinga Newsdesk
Monday, April 01, 2024
Ocuphire Announces the US Commercial Launch o...
Benzinga Newsdesk
Tuesday, March 26, 2024
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Avi Kapoor
Wednesday, March 20, 2024
Alliance Global Partners Maintains Buy on Ocu...
Benzinga Newsdesk
Monday, March 11, 2024
HC Wainwright & Co. Reiterates Buy on Ocuphir...
Benzinga Newsdesk
Friday, March 08, 2024
Ocuphire Pharma Q4 2023 GAAP EPS $(0.210) vs ...
Benzinga Newsdesk
Wednesday, February 14, 2024
Ocuphire Pharma Strengthens Leadership Team w...
Benzinga Newsdesk
Monday, February 05, 2024
Ocuphire Pharma Announces Presentation On APX...
Benzinga Newsdesk
Thursday, January 04, 2024
Ocuphire Pharma Receives FDA Agreement Under ...
Benzinga Newsdesk
Tuesday, November 28, 2023
Ocuphire Pharma Chief Operating Officer Awarded $855K Worth of Stock Options
Benzinga Insights
Monday, November 27, 2023
Ocuphire Pharma Announces Appointment Of Jose...
Benzinga Newsdesk
Monday, November 20, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Tuesday, November 14, 2023
HC Wainwright & Co. Reiterates Buy on Ocuphir...
Benzinga Newsdesk
Monday, November 13, 2023
Recap: Ocuphire Pharma Q3 Earnings
Benzinga Insights
Ocuphire Pharma Q3 EPS $0.25 Vs $(0.22) YoY, ...
Benzinga Newsdesk
Monday, November 06, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Thursday, November 02, 2023
Ocuphire Pharma Announces Successful End-of-P...
Benzinga Newsdesk
Wednesday, November 01, 2023
Ocuphire Pharma Announces Appointment Of Geor...
Benzinga Newsdesk
Tuesday, September 26, 2023
Watching Ocuphire Pharma; Note From Canaccord...
Benzinga Newsdesk
Ocuphire Pharma Inc Gets NDA Approval From FD...
Benzinga Newsdesk
Monday, September 11, 2023
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, August 14, 2023
Cantor Fitzgerald Reiterates Overweight on Oc...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Ocuphir...
Benzinga Newsdesk
Friday, August 11, 2023
On August 10, Ocuphire Pharma Inc Entered Into A Common Stock Purchase Agreement With Lincoln Park Capital Fund; Agreement Provides Co Can Sell To Lincoln Park Up To $50M Of Shares Of Co's Common Stock Over 30-Month Term Of Purchase Agreement
Happy Mohamed
Ocuphire Pharma Q2 EPS $(0.24) Misses $(0.23)...
Benzinga Newsdesk
Tuesday, June 27, 2023
Ocuphire Presents APX3330 ZETA-1 Clinical Data In Late-Breaker Session At The American Diabetes Association's Annual Conference
Happy Mohamed
Wednesday, June 21, 2023
Ocuphire Announces Late Breaking Presentation On APX3330 ZETA-1 Clinical Data At American Diabetes Association Annual Conference
Happy Mohamed
Monday, May 22, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Tuesday, May 16, 2023
HC Wainwright & Co. Reiterates Buy on Ocuphir...
Benzinga Newsdesk
Monday, May 15, 2023
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Ocuphire Pharma shares are trading lower afte...
Benzinga Newsdesk
Ocuphire Pharma Q1 EPS $(0.28) Misses $(0.15) Estimate, Sales $1.75M Miss $2.95M Estimate
Happy Mohamed
Monday, May 01, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Tuesday, April 25, 2023
Ocuphire Provides Corporate Update And Reiterates Previous Guidance On Clinical Programs; PDUFA Date Of September 28, 2023 Set For Nyxol; Preliminary Cash Balance As Of March 31, 2023 Of $39M Is Expected To Fund Operations Into 2025
Happy Mohamed
Friday, April 21, 2023
Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case
Melanie Schaffer
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
US Stocks Mostly Lower; Nasdaq Down 50 Points
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
